Outlook Therapeutics (41O.F) Q1 2025 Earnings

14FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.42
-1.19
-0.96
-0.72

Details

Expected EPS
-0.7242799999999999
Actual EPS
-0.84817
Surprise EPS
-0.12
Surprise Percent
+17.11%

Description

Outlook Therapeutics (41O.F) has reported earnings of -0.84817 per share for Q1 2025.

0 Comments

Share your thoughts